Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,380 across all filing types
Latest filing 2018-06-14 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE FOURTEENTH MEETING OF THE SEVENTH SESSION OF THE BOARD OF DIRECTORS
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting, detailing specific decisions such as social insurance fund integration and internal loans approval. It is a formal disclosure pursuant to securities regulations but does not contain financial statements or detailed financial performance data. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting result announcement. The content focuses on board decisions and approvals, which fits the category of Board/Management Information (MANG). The document length is 4132 characters, which is relatively short and typical for such announcements. Therefore, the classification is MANG with high confidence.
2018-06-14 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It relates to a general mandate granted to the board to repurchase H shares and informs creditors about their rights to claim against the company in relation to this repurchase. The document provides instructions for creditors to submit claims and does not contain financial statements or detailed financial data. It is a regulatory announcement informing stakeholders about the repurchase mandate and creditor claims process, not a financial report or detailed management discussion. The document length is about 5,271 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-06-04 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2018-06-04 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/05/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, including ordinary shares, preference shares, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, which fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed data on share capital changes, not just an announcement or a brief summary, so it is not a Report Publication Announcement or Regulatory Filing fallback. Therefore, the most appropriate classification is SHA with high confidence.
2018-06-04 English
SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OFTHE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under Rule 13.10B of the Hong Kong Stock Exchange listing rules. It relates to a general mandate granted to the board to repurchase H shares of the company and informs creditors about their rights to claim against the company in relation to this repurchase. The document does not contain financial statements or detailed financial data but is a regulatory announcement informing stakeholders about the repurchase mandate and creditor claims process. It is not a full financial report, earnings release, or management discussion. The document is over 5,000 characters but is essentially a regulatory announcement about a corporate action and creditor notification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-05-29 English
ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement made pursuant to disclosure requirements under the Hong Kong Stock Exchange rules. It informs creditors about the general mandate granted to the board to repurchase H shares and invites creditors to submit claims. The document is a formal announcement related to a corporate action (share repurchase mandate) and creditor notification, but it does not contain financial statements, detailed financial data, or management discussion. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or officer attestation. The document is a regulatory announcement informing stakeholders about the repurchase mandate and creditor rights, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-05-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.